Cited by 172Cannabis and Cannabinoid ResearchImmunotoxicology and immune responsesInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.

Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

Klein, Thomas W., Cabral, Guy A.·2006·Journal of Neuroimmune Pharmacology

DOI 10.1007/s11481-005-9007-x

Open this paper in CoChat — free account

Abstract

The study of marijuana cannabinoid biology has led to many important discoveries in neuroscience and immunology. These studies have uncovered a new physiological system, the endocannabinoid system, which operates in the regulation of not only brain function but also the regulation of the immune system. Studies examining the effect of cannabinoid-based drugs on immunity have shown that many cellular and cytokine mechanisms are suppressed by these agents leading to the hypothesis that these drugs may be of value in the management of chronic inflammatory diseases. In this report, we review current information on cannabinoid ligand and receptor biology, mechanisms involved in immune suppression by cannabinoids with emphasis on antigen-presenting cells, and preclinical and clinical models analyzing the therapeutic potential of cannabinoid-based drugs.

Integrity signals

Registry

Crossref · 10.1007/s11481-005-9007-x

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citation
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“Receptors A number of pharmacological studies with highaffinity ligands strongly supported the existence of cannabinoid receptors (Devane et al. 1988), and the gene for the first of these (CB1) was eventually cloned from brain in 1990 (Matsuda et al. 1990) with a second receptor (CB2) cloned a few…”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776

Show all 139 references

Sorted by citations

Items 101–172 of 172

Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
Sheng, W. S., Chauhan, P., Hu, S., Prasad, S., & Lokensgard, J. R. (2019) · Pain Research and Management · doi:10.1155/2019/1260353 · Cited by 18
Immunomodulatory Properties of Kappa Opioids and Synthetic Cannabinoids in HIV-1 Neuropathogenesis
Hu, S., Sheng, W. S., & Rock, R. B. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9306-3 · Cited by 18
Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights.
Lee, J., Sharma, N., Kazi, F., Youssef, I., Myers, A. K., Marmur, J. D., Salifu, M. O., & McFarlane, S. I. (2017) · PubMed · Cited by 17
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination after Hypoxia-Ischemia in Neonatal Rats
Carloni, S., Crinelli, R., Palma, L., Alvarez, F. J., Piomelli, D., Duranti, A., Balduini, W., & Alconada, D. A. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00047 · Cited by 17
Biological Networks in Ischemic Tolerance — Rethinking the Approach to Clinical Conditioning
Anrather, J., & Hallenbeck, J. M. (2013) · Translational Stroke Research · doi:10.1007/s12975-012-0244-z · Cited by 17
Morbidity and mortality associated with prescription cannabinoid drug use in COPD
Vozoris, N. T., Pequeno, P., Li, P., Austin, P. C., Stephenson, A. L., O’Donnell, D. E., Gill, S. S., Gershon, A. S., & Rochon, P. A. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215346 · Cited by 16
Novel approaches to the development of anti-sepsis drugs
Lehmann, C., Sharawy, N., Al-Banna, N., Corbett, N., Kuethe, J. W., & Caldwell, C. C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.905538 · Cited by 16
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours
Dada, S., Ellis, S. L. S., Wood, C. L., Nohara, L. L., Dreier, C., Garcia, N. H., Saranchova, I., Munro, L., Pfeifer, C. G., Eyford, B. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982082 · Cited by 16
Cannabis for the treatment of ulcerative colitis
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012954 · Cited by 15
Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019) · Current Bioactive Compounds · doi:10.2174/1573407214666180703130525 · Cited by 15
Potential of cannabinoids as treatments for autism spectrum disorders
Nezgovorova, V., Ferretti, C. J., Taylor, B. P., Shanahan, E. C., Uzunova, G., Hong, K., Devinsky, O., & Hollander, E. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.048 · Cited by 16
Drugs of abuse
Hill, S. L., & Thomas, S. H. L. (2016) · Medicine · doi:10.1016/j.mpmed.2015.12.030 · Cited by 16
GASTROINTESTINAL ENDOCANNABINOID SYSTEM: MULTIFACETED ROLES IN THE HEALTHY AND INFLAMED INTESTINE
Smid, S. D. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05016.x · Cited by 15
Cannabidiol and pain
Nascimento, G. C., Escobar-Espinal, D. M., Bálico, G. G., da Silva, N. R., & Del-Bel, E. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.016 · Cited by 14
Cannabinoid-induced changes in the immune system: The role of microRNAs
Bhatt, H. K., Song, D., Musgrave, G., & Rao, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107832 · Cited by 12
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up-regulation of Serum IgE Levels in Immunized Mice
Newton, C. A., & Klein, T. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9361-4 · Cited by 12
Self-citation
Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients
Taalab, Y. M., Mustafa, W., Helmy, M. A., Othman, A., Darwish, M., Hassan, I., & Abbas, M. A. A. (2019) · Brain Sciences · doi:10.3390/brainsci9120332 · Cited by 15
Drugs of Abuse and the Immune System
Eisenstein, T. K., Kaminsky, D. E., Rahim, R. T., & Rogers, T. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_37 · Cited by 12
The Cerebral Microcirculation
Tuma, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00013-9 · Cited by 11
Endocannabinoid System Biomarkers in Alzheimer's Disease
Ferreira, P. C. L., Bellaver, B., Povala, G., Brum, W. S., Tissot, C., Badji, A., Sloan, M. E., Benedet, A. L., Rosa‐Neto, P., Ashton, N. J., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0151 · Cited by 11
The Cerebral Microcirculation
Tuma, R. F. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020411 · Cited by 9
Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns
Barakat, M. M., Thiab, S. H., Alzaghari, L. F., Abdulrazzaq, S. B., Hasen, E., Abuarab, S. F., Nasereddin, L., Omar, A., Barakat, Y., Chellappan, D. K., et al. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100876 · Cited by 10
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome
Lehmann, C., Burkovskiy, I., Kuethe, J. W., Zhou, J., Caldwell, C. C., & Kelly, M. E. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.03.015 · Cited by 9
Role of Cannabinoids in Various Diseases: A Review
Roy, A., Kaur, S., & Sharma, N. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666211223164656 · Cited by 11
Immunology as it Pertains to Drugs of Abuse, AIDS and the Neuroimmune Axis: Mediators and Traffic
Rogers, T. J. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9247-2 · Cited by 9
Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion
Elliott, M. B., Ward, S. J., Abood, M. E., Tuma, R. F., & Jallo, J. (2017) · Concussion · doi:10.2217/cnc-2017-0010 · Cited by 8
Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey
Neufeld, T., Pfuhlmann, K., Stock‐Schröer, B., Kairey, L., Bauer, N., Häuser, W., & Langhorst, J. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1400-2768 · Cited by 8
Cannabidiol and Nano-Selenium Increase Microvascularization and Reduce Degenerative Changes in Superficial Breast Muscle in C. perfringens-Infected Chickens
Konieczka, P., Szkopek, D., Kinsner, M., Kowalczyk, P., Michalczuk, M., Bień, D., Banach, J., Matusevičius, P., & Bogucka, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010237 · Cited by 8
Role of Cannabis in the Incidence of Myocardial Infarction: A Review
Banerjee, A., Gandhi, A. B., Antony, I., Alexander, J., Hisbulla, M., Kannichamy, V., Kaleem, I., Mishra, V., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.11097 · Cited by 7
Cannabis Use Has Negligible Effects Following Severe Traumatic Injury
AbdelFattah, K. R., Edwards, C., Cripps, M. W., Minshall, C. T., Phelan, H. A., Minei, J. P., & Eastman, A. L. (2017) · Journal of Trauma Nursing · doi:10.1097/jtn.0000000000000277 · Cited by 6
Explaining Contemporary Patterns of Cannabis Teratology
Reece, A. S., & Hulse, G. K. (2019) · UWA Profiles and Research Repository (University of Western Australia) · doi:10.4172/2572-0775.1000146 · Cited by 6
URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
Demartini, C., Greco, R., Zanaboni, A. M., Francavilla, M., Facchetti, S., & Tassorelli, C. (2023) · Pharmaceuticals · doi:10.3390/ph16111626 · Cited by 6
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment
Ma, L., He, H., Liu, X., Zhang, G., Li, L., Song, Y., Li, K., & Shi, M. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv049 · Cited by 6
Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
Vozoris, N. T., Yao, Z., Li, P., Austin, P. C., Stephenson, A. L., Gill, S. S., O’Donnell, D. E., Gershon, A. S., & Rochon, P. A. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00707-3 · Cited by 6
Targeting Immunomodulatory Agents to the Gut-Associated Lymphoid Tissue
Zgair, A., Wong, J. C. M., & Gershkovich, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-28609-9_14 · Cited by 7
Endogenous Cannabinoids in Crohn’s Disease
Bochenek, M. S., Tomasik, J. T., Wędrychowicz, A., & Tomasik, P. (2024) · Applied Sciences · doi:10.3390/app14156646 · Cited by 5
Cannabinoid receptors modulate LPS-induced increase of class-II transactivator expression levels in a microglial cell line
Çankara, F. N., Çelik, Z. B., & Günaydın, C. (2021) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1868510 · Cited by 4
From Cannabis to the Endocannabinoid System: Refocussing Attention on Potential Clinical Benefits
Youssef, F. F., & Irving, A. J. (2012) · West Indian Medical Journal · doi:10.7727/wimj.2010.058 · Cited by 4
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Coschi, C. H., Ding, K., Tong, J., Tu, D., O’Callaghan, C., Leighl, N. B., Vera-Badillo, F., Juergens, R. A., Hao, D., Seymour, L., et al. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2485012 · Cited by 5
Cannabinoid receptor ligands with potential therapeutic applications and mechanisms of action: a versatile natural therapeutic agent
Tripathi, S. M., Sambhakar, S., Mishra, S. K., Malviya, R., & Sridhar, S. B. (2025) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2025.2522396 · Cited by 3
CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model
Leddy, R. S., Hudachek, C. L., Phelan, H. M., Aherne, C. M., Romero, J., Hillard, C. J., Wang, Z., Eißner, G., Jedlicka, P., & Collins, C. B. (2026) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izag066 · Cited by 3
Cannabinoids – Influence on the Immune System and Their Potencial Use in Supplementary Therapy of HIV/AIDS
Szulakowska, A., & Milnerowicz, H. (2011) · InTech eBooks · doi:10.5772/20420 · Cited by 2
Evaluation of 11-hydroxy-8-THC-dimethylheptyl effects on cytokines profile and locomotor tests in experimental autoimmune encephalomyelitis
Aarabi, M. H., Shahaboddin, M. E., Parastouei, K., Motallebi, M., Jafarnejad, A., Mirhashemi, S. M., & Hamidi, G. A. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9000607 · Cited by 2
Unmasking the cannabis paradox: in-hospital outcomes of cannabis users admitted with acute myocardial infarction over a 20-year period in the United States
Kumar, N., Paray, N. B., Ramphul, K., Verma, R., Dhaliwal, J. S., Schroeder, C., Liu, L., Bawna, F., Sakthivel, H., & Ahmed, R. (2024) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/189731 · Cited by 2
Drugs of Abuse
Eisenstein, T. K., & Rogers, T. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_41 · Cited by 2
The Use of Phytogenic Substances Against Chronic Stress: Opportunities and Challenges
Basiouni, S., El-Saedi, H., Téllez‐Isaías, G., Eisenreich, W., & Shehata, A. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-70480-2_8 · Cited by 1
The Uses of Cannabinoids in Medicine and Their Spectroscopic Applications
Er, A., & Çeli̇k, S. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch010 · Cited by 1
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint Inhibitors
Alsavaf, M. B., Issa, M., Klamer, B. G., Husain, M., Dibs, K. N., Pan, X. J., Grecula, J. C., Old, M. O., Konieczkowski, D. J., Mitchell, D., et al. (2024) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.14135 · Cited by 3
The Effects of Cannabinoids on Immune Cells, Responses and Diseases
Constantinescu, C. S., & Tănăsescu, R. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0888-8_11
Cannabinoids suppress dendritic cell-induced T helper cell polarization
Lu, T. (2006) · Digital Commons - University of South Florida (University of South Florida)
Cannabinoids Induce Immunoglobulin Class Switching to IgE in B Lymphocytes
Agudelo, M. (2009) · Digital Commons - University of South Florida (University of South Florida)
Neuroinflammation in first episodes of psychosis
Alcázar, M. B. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Evaluating the effect of HU-210 on cytokines profile and the clinical signs in the experimental model of multiple sclerosis
Aarabi, M. H., Shahaboddin, M. E., Parastouei, K., Motallebi, M., Jafarnejad, A., Mirhashemi, S. M., Hamidi, G. A., & Alvani, S. (2013) · Fiyz̤.
Factors associated with the severity of Apnoea Hypopnoea Index (AHI) in Obstructive Sleep Apnoea (OSA)
Earing, C. (2015) · Bangor University Research Portal (Bangor University)
Stress Response in Cannabis Users and Psychosis
Bioque, M., Tseng, H., & Mizrahi, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00033-8
The Psychoneuroimmunological Influences of Recreational Marijuana
Keen, L., Turner, A. D., Pereira, D. B., Callender, C. O., & Campbell, A. L. (2017) · STEAM-H: Science, Technology, Engineering, Agriculture, Mathematics & Health · doi:10.1007/978-3-319-55612-3_5
Cannabinoid Receptor and InflammationPreprint
Osafo, N., Yeboah, K. O., Antwi, A. O., & Ainooson, G. K. (2020) · doi:10.22541/au.159986420.00633539 · Cited by 1
Effect of synthetic cannabinoids (JWH-018) on antibody response to HBV vaccination
Köksoy, S., & Başalp, A. (2021) · Mehmet Akif Ersoy Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi · doi:10.24998/maeusabed.844896
Cannabinoids and the Skin
JAMES, S. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108583336.012
Regards croisés sur le cannabis
Seutin, V., Scuvée‐Moreau, J., & Quertemont, É. (2010) · Mardaga eBooks · doi:10.3917/mard.seuti.2010.01.0245
Comparative Safety Analysis of Nabilone Versus Opioids: A Population-Based Cohort Study
Vozoris, N. T., Fu, L., Austin, P. C., Stephenson, A. L., Gill, S. S., Chow, C., Ryan, C. M., & To, T. M. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08978-2
Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?
Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2
Drugs of Abuse
Eisenstein, T. K., & Rogers, T. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_33
Geospatiotemporal and causal inferential epidemiological survey and exploration of cannabinoid- and substance-related carcinogenesis in USA 2003–2017
Reece, A. S., & Hulse, G. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13492-0.00027-x
Multi-Modal Profiling Reveals Contrasting Immunomodulatory Effects of Recreational Marijuana Used Alone or with Tobacco in Youth with HIV
Borkar, S. A., Venturi, G. M., Chang, K.-F., Gu, J., Yin, L., Shen, J., Fischer, B. M., Nepal, U., Raplee, I., Kim-Chang, J. J., et al. (2025) · Cells · doi:10.3390/cells14161267
The Cerebral Microcirculation
Tuma, R. F. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01020.x
Microvascular Effects of Cannabinoids
Tuma, R. F., Li, H., Reichenbach, Z. W., Ward, S. J., & Elliott, M. B. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_12
Perceptions et comportements des personnes vivant avec le VIH co-infectées par le virus de l'hépatite C
Marcellin, F. (2016) · theses.fr (ABES) · doi:10.70675/94eb61ccz8bebz4ad5za78az90b65819be62
Cannabis
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Preserved Barrier Integrity and Altered Immune Profiles in Chronic Cannabis Users: Potential Roles of Δ9-TetrahydrocannabinolPreprint
McKinnon, J. E., Zhou, Z., Wagner, A. M., Luo, Z., Hartley, A., Wan, Z., Fitting, S., Haque, A., McRae‐Clark, A. L., & Jiang, W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736074
Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke
Bietar, B., Tanner, S., Abdolmohammadi, P., Kasheke, G. D. S., Zhou, J., & Lehmann, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117539
Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
(2020) · PubMed · doi:10.1093/ibd/izz233 · Cited by 19

Authors: Klein, T. W., & Cabral, G. A.
Affiliations: University of South Florida (US)
Virginia Commonwealth University (US)
Corresponding author: Klein, Thomas W.
ORCID: Klein, Thomas W.
Venue: Journal of Neuroimmune Pharmacology
Publisher: Springer Science and Business Media LLC
Published: 2006-02-22
Volume: 1
Issue: 1
Pages: 50-64
ISSN: 1557-1890 (ISSN-L)
1557-1904
DOI: 10.1007/s11481-005-9007-x
OpenAlex: W2061663043
Cited by: 172
References: 139
Citations by year: 2026: 4 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 11 · 2016: 13 · 2015: 6 · 2014: 9 · 2013: 13 · 2012: 6
FWCI: 0.94
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Journal of Neuroimmune Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA15608, DA05832, R01DA003646, DA03646, R01DA015608)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: cannabinoids, endocannabinoid system, immunosuppression, antigen-presenting cells, cannabinoid receptors, cytokines, chronic inflammatory diseases, immunomodulation
MeSH terms: Animals, Antigen-Presenting Cells, Cannabinoids, Cannabis, Humans, Inflammation, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks